Authors: Fontana, RJ Hann, HWL Wright, T Everson, G Baker, A Schiff, ER Riely, C Anschuetz, G Riker-Hopkins, M Brown, N

Citation: Rj. Fontana et al., A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation, LIVER TRANS, 7(6), 2001, pp. 504-510

Authors: Perrillo, RP Wright, T Rakela, J Levy, G Schiff, E Gish, R Martin, P Dienstag, J Adams, P Dickson, R Anschuetz, G Bell, S Condreay, L Brown, N

Citation: Rp. Perrillo et al., A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis, HEPATOLOGY, 33(2), 2001, pp. 424-432

Authors: Naoumov, NV Lopes, AR Burra, P Caccamo, L Iemmolo, RM de Man, RA Bassendine, M O'Grady, JG Portmann, BC Anschuetz, G Barrett, CA Williams, R Atkins, M

Citation: Nv. Naoumov et al., Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation, J HEPATOL, 34(6), 2001, pp. 888-894

Authors: Mutimer, D Dusheiko, G Barrett, C Grellier, L Ahmed, M Anschuetz, G Burroughs, A Hubscher, S Dhillon, AP Rolles, K Elias, E

Citation: D. Mutimer et al., Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up, TRANSPLANT, 70(5), 2000, pp. 809-815

Authors: Perrillo, R Rakela, J Dienstag, J Levy, G Martin, P Wright, T Caldwell, S Schiff, E Gish, R Villeneuve, JP Farr, G Anschuetz, G Crowther, L Brown, N

Citation: R. Perrillo et al., Multicenter study of lamivudine therapy for hepatitis B after liver transplantation, HEPATOLOGY, 29(5), 1999, pp. 1581-1586